BioCryst Pharmaceuticals, Inc.
Supplier Profile
Overview
Updated August 2024
US
Incorporated Country
20
Subsidiaries
35
Tier 1 Connections
$32.73M
Prime Awards
Supplier Summary
Top Funding Offices
Agency | Sub-Agency | Funding Office | Prime Contract Awards |
Department of Health and Human Services | Office of Assistant Secretary for Preparedness and Response | OFF ASST SEC ADM AND MGMT | $95,257,377 |
Department of Health and Human Services | Office of Assistant Secretary for Preparedness and Response | BARDA - ASPR / DAAPPO / BARDA DCMA | $30,604,178 |
Department of Health and Human Services | National Institutes of Health | NIH, NIAID DEA OA OFC ACQUISITIONS | $29,875,052 |
Department of Health and Human Services | National Institutes of Health | NATIONAL INSTITUTES OF HEALTH NIAID | $24,207,150 |
Department of Health and Human Services | Centers for Disease Control and Prevention | CDC OFFICE OF ACQUISITION SERVICES | $6,932,000 |
Top Subsidiaries
Company Name | Country Code | Count of Contracts | Total Award Amount |
BioCryst Canada ULC | CA | 0 | $0 |
BioCryst Schweiz GmbH | CH | 0 | $0 |
BioCryst Schweiz GmbH | CH | 0 | $0 |
BioCryst Pharma Deutschland GmbH | DE | 0 | $0 |
BioCryst Pharma Deutschland GmbH | DE | 0 | $0 |
Recent Tier 1 Suppliers
Name | Relationship | Country | Start Date |
Clearside Biomedical, Inc. | SUPPLIER | US | 2/29/24 |
Fiscalnote Holdings, Inc. | SUPPLIER | US | 8/4/23 |
Royalty Pharma plc | SUPPLIER | US | 6/7/21 |
UNIVERSITY OF ALABAMA AT BIRMINGHAM | SUPPLIER | US | 5/26/19 |
Yeshiva University | SUPPLIER | US | 4/29/15 |
Top Contracts
Contract ID | Entity Name | Dollars Awarded | Funding Office |
75D30118C02984 | BioCryst Pharmaceuticals, Inc. | $20,796,000 | BARDA - ASPR / DAAPPO / BARDA DCMA |
75N93020C00055 | BioCryst Pharmaceuticals, Inc. | $6,326,480 | NATIONAL INSTITUTES OF HEALTH NIAID |
HHSN272201300017C | BioCryst Pharmaceuticals, Inc. | $4,721,121 | NATIONAL INSTITUTES OF HEALTH NIAID |
36C26024F0270 | BioCryst Pharmaceuticals, Inc. | $385,448 | 260-NETWORK CONTRACT OFFICE 20 (36C260) |
36C26024F0258 | BioCryst Pharmaceuticals, Inc. | $201,722 | 260-NETWORK CONTRACT OFFICE 20 (36C260) |
List of UEIs for BioCryst Pharmaceuticals, Inc.
MGXADJ6SCLJ5
ABOUT SUPPLIER ANALYSIS
Ark.ai provides definitive, consolidated analyses of every vendor, subcontractor, supplier, grant awardee, non-profit, and investment organization in the national security and defense sectors. Organization profile pages provide a real-time view of the companies that impact critical government programs.
EXPLORE ADDITIONAL ANALYSES
ABOUT ARK.AI
The Ark is the only software platform purpose-built for Defense Acquisition that leverages authoritative commercial data and AI-enabled Applications designed to solve Acquisition challenges. With the Ark, analysts and decision-makers gain the ability to manage Acquisition programs proactively, allowing them to unwind the legacy complexity and effectively field modern warfighting systems that compete with China.
The Leading Defense Acquisition Software.
OUR APPLICATIONS
AI-enabled Applications within The Ark reflect standard workflows across the Defense Acquisition Process. From Science & Technology to Modernization, these Applications allow for the execution of rapid, efficient, data-informed decisions, standardized reporting, and efficient workflow management. The Ark enables your team to transform Defense Acquisition into a strategic advantage.